AVROBIO

AVROBIO

Company Details

WebsiteLinkedIn

Status: Public

Employees: 101-250

Location:

Cambridge, Massachusetts, United States of America

Type:

sample

Technology:

sample

sample

sample

sample

sample

sample

Description: Our vision is to bring personalized gene therapy to the world. We target the root cause of genetic disease by introducing a functional copy of the affected gene into patients’ own hematopoietic stem cells (HSCs), with the goal of durably expressing the therapeutic protein throughout the body, including the central nervous system. Our first-in-class pipeline includes clinical programs for Gaucher disease and Hunter syndrome, as well as a preclinical program for Pompe disease. Our proprietary plato® gene therapy platform is scalable for planned global commercialization. We are headquartered in Cambridge, Mass. For additional information, visit avrobio.com, and follow us on Twitter and LinkedIn.
Unlock access to company contacts, hot leads, and drug pipelines.
Log in or create a free account now!
BiopharmIQ
AVROBIO | Active clinical trials on ClinicalTrials.gov

Active Clinical Trials Count | 0

No Active Trials Found On ClinicalTrials.gov.